Babich Michael L
President and CEO at Insys Therapeutics, Inc.
- Sold, on record
- $29.8M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Mar 17, 2015
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Insys Therapeutics, Inc.President and CEO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Insys Therapeutics, Inc.UnusualMar 5 2014
Sold 288,432 shares at $74.58 ($21.5M)
Babich Michael L, President and CEO
Sold 98.2% of holdings ($21.9M position)5,375 shares leftFirst sale on recordFiling
- 2 Form 4 sale Insys Therapeutics, Inc.Plan not statedOct 21 +230 days
Sold 20,000 shares at $40.17 ($803k)
Babich Michael L, President and CEO
Sold 10.5% of holdings ($7.6M position)169,795 shares leftFiling
- 3 Form 4 sale Insys Therapeutics, Inc.UnusualNov 4 +14 days
Sold 80,000 shares at $38.66 ($3.1M)
Babich Michael L, President and CEO
Sold 32% of holdings ($9.7M position)169,795 shares leftFiling
- 4 Form 4 sale Insys Therapeutics, Inc.UnusualMar 17 +133 days
Sold 75,000 shares at $58.63 ($4.4M)
Babich Michael L, President and CEO
Sold 27% of holdings ($16.3M position)202,752 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 17, 2015 | Insys Therapeutics, Inc. | President and CEO | Form 4 sale | 75,000 | $4.4M | 27.0% | Unusual | SEC |
| Nov 4, 2014 | Insys Therapeutics, Inc. | President and CEO | Form 4 sale | 80,000 | $3.1M | 32.0% | Unusual | SEC |
| Oct 21, 2014 | Insys Therapeutics, Inc. | President and CEO | Form 4 sale | 20,000 | $803k | 10.5% | Plan not stated | SEC |
| Mar 5, 2014 | Insys Therapeutics, Inc. | President and CEO | Form 4 sale | 288,432 | $21.5M | 98.2% | Unusual | SEC |